What is Viatris's north america segment — impairment of goodwill?

Viatris (VTRS) reported north america segment — impairment of goodwill of -$707.00M in Q1 2025.

What does north america segment — impairment of goodwill mean?

The amount by which the value of goodwill in the North American segment has been written down due to a decline in expected future performance.

Discontinued — last reported Q1 '25

Business Segments · Impairment of goodwill

North America Segment — Impairment of goodwill

Analysis

StatementSegment

CategoryRisk

SignalLower is better

VolatilityVolatile

First reportedQ1 2025

Last reportedQ1 2025

Rolls up toGoodwill impairment

How to read this metric

An increase indicates a negative reassessment of the segment's future cash flows or market competitiveness, signaling potential operational challenges.

Detailed definition

This metric quantifies the non-cash charge recognized when the carrying amount of goodwill in the North American segment...

Peer comparison

Commonly reported by large-cap pharmaceutical firms during periods of portfolio restructuring or market shifts; peers often disclose this in segment footnotes.

Metric ID: vtrs_segment_north_america_segment_impairment_of_goodwill

Historical Data

1 periods

	Q1 '25
Value	-$707.00M

Similar Metrics at Other Companies

Ralph LaurenRL View metric

Smurfit Kappa GroupSW View metric

The Kraft Heinz CompanyKHC View metric

Willis Towers WatsonWTW View metric

Johnson Controls InternationalJCI View metric

Frequently Asked Questions

What is Viatris's north america segment — impairment of goodwill?: Viatris (VTRS) reported north america segment — impairment of goodwill of -$707.00M in Q1 2025.
What does north america segment — impairment of goodwill mean?: The amount by which the value of goodwill in the North American segment has been written down due to a decline in expected future performance.